Table 3.
Number of vaccine doses received among study participants by year.
| No. of PCV doses | 2014–2015 (n = 771) | 2015–2016 (n = 780) | 2016–2017 (n = 779) | 2017–2018 (n = 810) | 2014–2018 (n = 3140) |
|---|---|---|---|---|---|
| 0 dose % (95%CI) | 35.0 (31.7–38.5) |
19.9 (17.1–22.8) |
11.0 (8.9–13.5) |
9.5 (7.6–11.7) |
18.7 (17.4–20.1) |
| 1 dose % (95%CI) | 11.0 (8.9–13.4) |
13.8 (11.5–16.5) |
10.9 (8.8–13.3) |
9.0 (7.1–11.2) |
11.2 (10.1–12.3) |
| 2 doses % (95%CI) | 13.0 (10.7–15.5) |
11.7 (9.5–14.1) |
12.1 (9.9–14.6) |
13.1 (10.8–15.6) |
12.5 (11.3–13.7) |
| 3 doses% (95%CI) | 41.0 (37.5–44.6) |
54.6 (51.0–58.2) | 66.0 (62.5–69.3) |
68.4 (65.1–71.6) |
57.6 (55.9–59.4) |
p-value for trend 0.001.